The treatment landscape of Inflammatory Bowel Disease (IBD) has undergone a significant transformation over the past two ...

Johnson & Johnson, a leader in immunology, has developed ARGES, a new AI-powered tool that could transform endoscopic ...

Noninvasive monitoring methods, such as enterography and ultrasound, are becoming increasingly recognized as essential tools ...

An international team led by researchers at the University of Toronto has found a compound in ginger, called furanodienone ...

Extraintestinal manifestations and arthralgia are significant predictors of IBD-related arthritis among patients with CD, while sacroiliitis was not associated.

A new thesis from Karolinska Institutet aims to advance our understanding of the bidirectional relationship between ...

The mystery of why people with Inflammatory Bowel Disease (IBD) have a four times higher risk of getting life threatening ...

Switching back from infliximab biosimilar SB2 to reference infliximab (Remicade) did not affect clinical disease activity or ...

Inflammatory bowel disease (IBD) affects between 2.4 and 3.1 million people across the United States, according to the ...

Switching from IV to subcutaneous infliximab maintenance therapy is associated with high treatment persistence and a stable ...